A live map of the Biotech sector: 478 companies tracked, $18.1B raised across 564 funding rounds. Below: the most-funded companies, the investors most active in Biotech, and the latest rounds.
| Company | Rounds | Raised |
|---|---|---|
| Isomorphic Labs | 1 round | $2.1B |
| BioLife Solutions | 1 round | $1.5B |
| Xaira Therapeutics | 1 round | $1B |
| Coefficient Bio | 1 round | $400M |
| Tubulis | 1 round | $357M |
| Normax Biomed | 1 round | $300M |
| Calypso Biotech | 2 rounds | $278M |
| Cellares | 1 round | $277M |
| Altos Labs | 1 round | $270M |
| Colossal Biosciences | 2 rounds | $270M |
| Noema Pharma | 2 rounds | $250.5M |
| Leyden Labs | 4 rounds | $245M |
| Chai Discovery | 2 rounds | $200M |
| Asimov | 1 round | $200M |
| Genesis Therapeutics | 1 round | $200M |
| Adcendo | 3 rounds | $185.8M |
| DNA Script | 1 round | $176.8M |
| Vaccitech | 1 round | $168M |
| Bionyra Pharma | 1 round | $165M |
| Complement Therapeutics | 2 rounds | $149M |
| VectorY Therapeutics | 1 round | $138M |
| Hemab Therapeutics | 1 round | $135M |
| MinervaX | 3 rounds | $134.3M |
| Crystalys Therapeutics | 1 round | $130M |
| Jul 2026 | Crystalys Therapeutics — series b | $130M |
| Jul 2026 | BioLife Solutions — round | $1.5B |
| Jul 2026 | Brenus Pharma — series a | $12.6M |
| Jul 2026 | Immitra Bio — pre seed | $2.8M |
| Jul 2026 | Sightera Biosciences — pre seed | $3.2M |
| Jul 2026 | Alchemab Therapeutics — series a | $34M |
| Jul 2026 | Telum Therapeutics — series a | $20.7M |
| Jun 2026 | Epitome Therapeutics — pre seed | $2.3M |
| Jun 2026 | Thalia Therapeutics — unknown | $3.6M |
| Jun 2026 | Sanmirna Therapeutics — round | $4.8M |